FI885869A - CYCLOSPORINE AND FAR OIL DESSION FRAMSTAELLNING. - Google Patents

CYCLOSPORINE AND FAR OIL DESSION FRAMSTAELLNING. Download PDF

Info

Publication number
FI885869A
FI885869A FI885869A FI885869A FI885869A FI 885869 A FI885869 A FI 885869A FI 885869 A FI885869 A FI 885869A FI 885869 A FI885869 A FI 885869A FI 885869 A FI885869 A FI 885869A
Authority
FI
Finland
Prior art keywords
dession
framstaellning
cyclosporine
far oil
far
Prior art date
Application number
FI885869A
Other languages
Finnish (fi)
Other versions
FI89065B (en
FI89065C (en
FI885869A0 (en
Inventor
Danielle Giron
Martin List
Friedrich Richter
Yasuyuki Uike
Hans Peter Weber
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI885869A0 publication Critical patent/FI885869A0/en
Publication of FI885869A publication Critical patent/FI885869A/en
Publication of FI89065B publication Critical patent/FI89065B/en
Application granted granted Critical
Publication of FI89065C publication Critical patent/FI89065C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI885869A 1987-12-21 1988-12-19 FREQUENCY REFRIGERATION FOR CYCLOSPORIC CRYSTAL FORM FI89065C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US13623087 1987-12-21
US17261388A 1988-03-24 1988-03-24
US17261388 1988-03-24
US21254888A 1988-06-28 1988-06-28
US21254888 1988-06-28

Publications (4)

Publication Number Publication Date
FI885869A0 FI885869A0 (en) 1988-12-19
FI885869A true FI885869A (en) 1989-06-22
FI89065B FI89065B (en) 1993-04-30
FI89065C FI89065C (en) 1993-09-30

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885869A FI89065C (en) 1987-12-21 1988-12-19 FREQUENCY REFRIGERATION FOR CYCLOSPORIC CRYSTAL FORM

Country Status (27)

Country Link
JP (1) JPH0791316B2 (en)
KR (1) KR100188305B1 (en)
AT (1) AT403163B (en)
AU (1) AU626274B2 (en)
BE (1) BE1002665A4 (en)
CA (1) CA1341396C (en)
CH (1) CH677926A5 (en)
CY (1) CY1799A (en)
DE (1) DE3843054C2 (en)
DK (1) DK175220B1 (en)
ES (1) ES2012580A6 (en)
FI (1) FI89065C (en)
FR (1) FR2624863B1 (en)
GB (1) GB2211848B (en)
GR (1) GR1002486B (en)
HK (1) HK102894A (en)
HU (1) HU203564B (en)
IE (1) IE62006B1 (en)
IL (1) IL88719A0 (en)
IT (1) IT1235356B (en)
LU (1) LU87409A1 (en)
MY (1) MY103943A (en)
NL (1) NL195096C (en)
NO (1) NO177228C (en)
NZ (1) NZ227384A (en)
SE (1) SE503174C2 (en)
SG (1) SG99494G (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
PT589843E (en) 1992-09-25 2002-04-29 Novartis Ag PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
PT789580E (en) 1994-11-03 2002-09-30 Novartis Ag CYCLOSPORINE FORMULATIONS FOR ORAL ADMINISTRATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY AND PROCESS FOR ITS PRODUCTION
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (en) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations
US6262054B1 (en) * 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
RU2211047C2 (en) 1997-01-30 2003-08-27 Новартис Аг Gelatin capsule with solid film including oil-free pharmaceutically compositions
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE602005011928D1 (en) 2004-01-20 2009-02-05 Allergan Inc COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, PREFERABLY CONTAINING TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID
CN1763084B (en) * 2005-10-11 2010-04-21 山东新时代药业有限公司 High purity cyclosporin A preparation method
BR112013030554B1 (en) 2011-05-27 2020-12-15 Allergan, Inc. CRYSTALLINE FORM OF CYCLOSPORIN A, METHODS OF PREPARATION AND METHODS FOR USE OF THE SAME
CN104080442B (en) 2011-11-15 2018-01-05 阿勒根公司 The suspension of cyclosporin A form 2
KR102072252B1 (en) 2011-11-15 2020-01-31 알러간, 인코포레이티드 Cyclosporin a form 2 and method of making same
ES2675269T3 (en) * 2011-11-15 2018-07-10 Allergan, Inc. Treatable autoclavable suspensions of cyclosporin A form 2
CN108175742B (en) 2011-11-15 2021-10-22 阿勒根公司 Sustained action formulation of cyclosporin form 2

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (en) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (en) * 1977-05-10 1978-11-23 Sandoz Ag CYCLOSPORIN DERIVATIVES, THEIR USE AND MANUFACTURING
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
JPH0791316B2 (en) 1995-10-04
NZ227384A (en) 1991-09-25
NO177228B (en) 1995-05-02
NL8803125A (en) 1989-07-17
IL88719A0 (en) 1989-07-31
IT8848690A0 (en) 1988-12-20
DK705488D0 (en) 1988-12-19
GB2211848B (en) 1991-11-06
KR890009975A (en) 1989-08-05
IE883779L (en) 1989-06-21
GR1002486B (en) 1996-12-09
IT1235356B (en) 1992-06-30
ES2012580A6 (en) 1990-04-01
SG99494G (en) 1994-10-28
FR2624863B1 (en) 1991-04-26
KR100188305B1 (en) 1999-06-01
CY1799A (en) 1995-02-17
HK102894A (en) 1994-09-30
SE8804570D0 (en) 1988-12-19
IE62006B1 (en) 1994-12-14
CA1341396C (en) 2002-11-05
HUT49893A (en) 1989-11-28
DE3843054A1 (en) 1989-07-27
JPH01211598A (en) 1989-08-24
GB2211848A (en) 1989-07-12
NL195096C (en) 2004-02-09
AU2705588A (en) 1989-06-22
NO177228C (en) 1995-08-09
BE1002665A4 (en) 1991-04-30
LU87409A1 (en) 1989-07-07
AT403163B (en) 1997-11-25
ATA309588A (en) 1997-04-15
DK175220B1 (en) 2004-07-12
FI89065B (en) 1993-04-30
GR880100850A (en) 1994-03-31
SE503174C2 (en) 1996-04-15
CH677926A5 (en) 1991-07-15
HU203564B (en) 1991-08-28
NO885625L (en) 1989-06-22
DK705488A (en) 1989-06-22
GB8829556D0 (en) 1989-02-08
FI89065C (en) 1993-09-30
AU626274B2 (en) 1992-07-30
MY103943A (en) 1993-10-30
DE3843054C2 (en) 2003-08-21
NO885625D0 (en) 1988-12-19
FI885869A0 (en) 1988-12-19
SE8804570L (en) 1989-06-22
FR2624863A1 (en) 1989-06-23

Similar Documents

Publication Publication Date Title
FI885869A0 (en) CYCLOSPORINE AND FAR OIL DESSION FRAMSTAELLNING.
FI883436A0 (en) VAETSKEBEHAOLLARE OCH DESS FRAMSTAELLNINGSFOERFARANDE.
FI885148A0 (en) SIKTKORG OCH FOERFARANDE FOER DESS TILLVERKNING.
FI881372A (en) KATALYTUNDERLAG OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI884318A0 (en) IMIDAZOPYRIDINFOERENING OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI862608A (en) THIAZOLIN-4 (S) -CARBOXYL SYRADERIVES AND FAR OIL FAR OIL DERAS FRAMSTAELLNING.
FI884256A0 (en) LIVSMEDELSFOERPACKNING OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI880453A (en) NARKOSMEDELKOMPOSITION OCH FOERFARANDE FOER DESS ANVAENDNING.
FI893269A (en) SPRICKOR DETEKTERANDE GLASSKIVA OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI881339A0 (en) KOMPAKTLYSROER OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI884912A (en) MODIFIED OIL ELLEDANDE POLYMERER.
FI880543A0 (en) LYFTSTROPP OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI873285A0 (en) FIBERARMERAT ROERELEMENT OCH FOERFARANDE FOER DESS TILLVERKNING.
FI884004A0 (en) BENZOFURANDERIVAT OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI880875A (en) HAORKOSMETISK SAMMANSAETTNING OCH DESS FRAMSTAELLNINGSFOERFARANDE.
FI872837A0 (en) SKIVMATERIAL OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI870757A (en) LYFTSTROPP OCH FOERFARANDE FOER DESS TILLVERKNING.
FI870761A (en) FILMAGGREGAT OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI875277A (en) VAEXTMEDIUM OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI884320A (en) JAESTEXTRAKT OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI875709A (en) SAORFOERBAND OCH DESS FRAMSTAELLNING.
FI874052A0 (en) TRYCKALSTER OCH DESS AVSAENDNINGSFOERFARANDE.
FI871395A0 (en) NYTT VAGINALT PREVENTIV OCH DESS BORTTAGNINGSANORDNING.
FI871412A0 (en) ELEKTRISKT INSTALLATIONSDON OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
FI870242A0 (en) ANTIHYPOXIAMEDEL OCH FOERFARANDE FOER DESS ANVAENDNING.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: NOVARTIS AG

BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired